Literature DB >> 8803652

First report of mirtazapine overdose.

M J Hoes1, J H Zeijpveld.   

Abstract

This report describes what is thought to be the first case of mirtazapine overdose occurring since the introduction of the antidepressant drug (Remeron) in the Netherlands in 1994. It is suggested that mirtazapine has a benign side effect profile when taken in overdose.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8803652

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN： 0268-1315            Impact factor:   1.659


  5 in total

Review 1.  Third-generation antidepressants: do they offer advantages over the SSRIs?

Authors:  J S Olver; G D Burrows; T R Norman
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 2.  Mirtazapine: a review of its use in major depression.

Authors:  K J Holm; A Markham
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

Review 3.  A risk-benefit assessment of mirtazapine in the treatment of depression.

Authors:  S Kasper; N Praschak-Rieder; J Tauscher; R Wolf
Journal:  Drug Saf       Date:  1997-10       Impact factor: 5.606

Review 4.  'Atypical' antidepressants in overdose: clinical considerations with respect to safety.

Authors:  Nicholas A Buckley; Thomas A Faunce
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

5.  Mirtazapine overdose is unlikely to cause major toxicity.

Authors:  I Berling; G K Isbister
Journal:  Clin Toxicol (Phila)       Date:  2013-11-14       Impact factor: 4.467
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.